TNFRSF6B, DCR3, TR6, M68
Recombinant Human TNFRSF6B /DcR3 Protein,C-Fc Tag,HEK293 expressed (rh TNFRSF6B / DcR3 Fc Chimera) Val 30 - His 300 (Accession # AAH17065) was produced in human 293 cells (HEK293) at ACROBiosystems.
rh TNFRSF6B / DcR3 Fc Chimera is fused with a human IgG1 Fc tag at the C-terminus, and has a calculated MW of 56.4 kDa. The predicted N-terminus is Val 30. DTT-reduced Protein migrates as 64 kDa in SDS-PAGE due to glycosylation.
Less than 1.0 EU per μg of the rh TNFRSF6B / DcR3 Fc Chimera by the LAL method.
>85% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in 50 mM tris, 100 mM glycine, pH7.5. Normally Mannitol or Trehalose are added as protectants before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4oC); After reconstitution under sterile conditions for 3 months (-70oC).
Tumor necrosis factor receptor superfamily member 6B (TNFRSF6B) is also known as Decoy Receptor 3 (DcR3), Decoy receptor for Fas ligand and M68, which belongs to the tumor necrosis factor receptor superfamily. TNFRSF6 is a soluble protein which contains four TNFR-Cys repeats. Unlike most of the other members of TNFR superfamily, TNFRSF6 is a soluble protein which contains no transmembrane domain. TNFRSF6B acts as a decoy receptor that competes with death receptors for ligand binding. The protein is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death and T cell activation as well as to induce angiogenesis via neutralization of TL1A.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.